Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Literature
1.
Prisco D, Ageno W, Becattini C, D'Angelo A, Davì G, De Cristofaro R, Dentali F, Di Minno G, Falanga A, Gussoni G, Masotti L, Palareti G, Pignatelli P, Santi RM, Santilli F, Silingardi M, Tufano A, Violi F, SIMI (Italian Society of Internal Medicine), FADOI (Federation of Associations of Hospital Doctors on Internal Medicine), SISET (Italian Society for the Study of Haemostasis and Thrombosis) (2017) Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med 12:387–406. https://​doi.​org/​10.​1007/​s11739-017-1628-6 CrossRefPubMed
2.
Shunkwiler SM, Pham HP, Wool G, Ipe TS, Fang DC, Biller E, Treml A, Weiss J, Baron BW, Berg M, Therapeutic Apheresis Subsection of the AABB (2018) The management of anticoagulation in patients undergoing therapeutic plasma exchange: a concise review. J Clin Apheresis 33:371–379. https://​doi.​org/​10.​1002/​jca.​21592 CrossRefPubMed
3.
4.
5.
6.
7.
Metadata
Title
Direct oral anticoagulants in lipoprotein apheresis: handle with care
Authors
Francesco Sbrana
Beatrice Dal Pino
Angela Papa
Federico Bigazzi
Luca Panchetti
Tiziana Sampietro
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 7/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02118-z

Other articles of this Issue 7/2019

Internal and Emergency Medicine 7/2019 Go to the issue

IM - Editorial

Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence

CE - MEDICAL ILLUSTRATION

Large paraganglioma at the organ of Zuckerkandl

IM - ORIGINAL

Comparison of Reverse Triage with National Early Warning Score, Sequential Organ Failure Assessment and Charlson Comorbidity Index to classify medical inpatients of an Italian II level hospital according to their resource’s need

CE - MEDICAL ILLUSTRATION

Pyogenic liver abscess caused by accidental ingestion of a bottle cap

IM - COMMENTARY

Is circulating endothelin evaluation useful for clinicians?

Points of View

Why include the humanities in medical studies?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits